Regenerative Medical Technology Group Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2026-06-30 was $9.12K.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-12-31 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2024-09-30 was $1.80K.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $8.06K, a 145.14% increase year-over-year.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for fiscal 2025 was $22.00K, a 1121.54% increase from fiscal 2024.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for fiscal 2024 was $1.80K.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for fiscal 2020 was $14.74K, a 42.29% decline from fiscal 2019.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of convertible securities for fiscal 2019 was $25.55K, a 15.55% decline from fiscal 2018.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2026-06-30 | $9.12K 10-Q · filed 2026-08-19 | |
| 2025-12-31 | $22.00K 10-K · filed 2026-05-14 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-14 | $1.80K 10-K · filed 2026-05-14 |
| 2024-09-30 | $1.80K 10-Q · filed 2025-11-19 | |
| 2021-06-30 | $8.06K 10-Q · filed 2022-08-15 | $24.91K derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $7.97K 10-Q · filed 2022-05-19 | $20.13K derived: sum of 4 quarters · filed 2022-05-19 |
| 2020-12-31 | $4.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-05 | $14.74K 10-K · filed 2022-05-05 |
| 2020-09-30 | $4.12K 10-Q · filed 2021-12-22 | $23.10K derived: sum of 4 quarters · filed 2021-12-22 |
| 2020-06-30 | $3.29K 10-Q · filed 2021-08-13 | $31.42K derived: sum of 4 quarters · filed 2021-08-13 |
| 2020-03-31 | $2.58K 10-Q · filed 2021-01-07 | |
| 2019-12-31 | $13.10K derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-13 | $25.55K 10-K · filed 2021-04-13 |
| 2019-09-30 | $12.44K 10-Q · filed 2019-11-15 | |
| 2018-12-31 | $14.02K derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-09 | $30.25K 10-K · filed 2020-12-09 |